The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet
Author(s) -
Stefan Lutz,
Anita M. Hennige,
Andreas Peter,
Markéta Kovářová,
Charisis Totsikas,
Jürgen Machann,
Stefan Kröber,
Bianca Sperl,
Erwin Schleicher,
Fritz Schick,
Martin Heni,
Axel Ullrich,
HansUlrich Häring,
Norbert Stefan
Publication year - 2018
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2018-01573
Subject(s) - medicine , endocrinology , lipogenesis , lipid metabolism , fgf21 , biology , insulin , fatty liver , triglyceride , carbohydrate metabolism , insulin resistance , cholesterol , receptor , fibroblast growth factor , disease
The effect of a lifestyle intervention to reduce liver fat content in nonalcoholic fatty liver disease in humans is influenced by genetics. We hypothesized that the amino acid exchange in human Gly388Arg (mouse homolog: Gly385Arg) in fibroblast growth factor receptor 4 (FGFR4), which regulates bile acid, lipid, and glucose metabolism, could determine hepatic lipid accumulation and insulin sensitivity. Mechanisms of this substitution were studied in mice under normal chow and high-fat diets.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom